Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EVAXION BIOTECH A/S

(EVAX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Monday Trading

10/25/2021 | 12:03pm EST


ę MT Newswires 2021
All news about EVAXION BIOTECH A/S
11/25BIOSTOCK : Capital injection sets Evaxion Biotech up for phase IIb trials
AQ
11/10EVAXION BIOTECH A/S INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEME..
PU
11/09Evaxion Biotech Announces Closing of $27.6 Million Follow-on Public Offering, Including..
PU
11/09Evaxion Biotech Announces Closing of $27.6 Million Follow-on Public Offering, Including..
AQ
11/09Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update - Form..
PU
11/09Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update
AQ
11/09Evaxion Biotech A/S Reports Earnings Results for the Third Quarter and Nine Months Ende..
CI
11/05Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering - Form 6-K
PU
11/05Top Premarket Decliners
MT
11/05Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering
AQ
More news
Analyst Recommendations on EVAXION BIOTECH A/S
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -23,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,96x
Yield 2021 -
Capitalization 108 M 108 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 35
Free-Float 50,0%
Chart EVAXION BIOTECH A/S
Duration : Period :
Evaxion Biotech A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVAXION BIOTECH A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 4,66 $
Average target price 18,00 $
Spread / Average Target 286%
EPS Revisions
Managers and Directors
Lars Aage Staal Wegner Chief Executive Officer
Glenn S. Vraniak Chief Financial Officer
Marianne S°gaard Chairman
Erik Deichmann Heegaard Chief Medical Officer
Birgitte Rono Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
EVAXION BIOTECH A/S0.00%108
MODERNA, INC.237.35%142 893
LONZA GROUP AG30.63%59 859
IQVIA HOLDINGS INC.44.63%49 504
SEAGEN INC.-8.64%29 257
CELLTRION, INC.-42.34%23 827